Time for a new episode of Tomorrow! Today we're talking about the paradigm shift in defense that's taking place in Europe, where member states are actively working to increase defense spending after decades of under-investment. But the region needs to get funding, strategy and implementation right. In this episode, Allianz Research's AI Assistant Aria explai ... Show More
Jul 7
Mid-year economic outlook 2025-26: Summertime sadness
The global economy has got that summertime, summertime sadness. Global GDP growth could hit the slowest pace since 2008 this year, outside of recession periods, according to our mid-year economic outlook for 2025-26. The US is expected to grow by +1.6%, helped by lower effective ... Show More
4m 39s
Jun 18
The transatlantic divide in Working Capital Requirements
Time for a new episode of Tomorrow! Today, we’re diving into a crucial – but often overlooked – indicator of business health: Working Capital Requirements. WCR is the financial canary in the coal mine, revealing how efficiently companies are managing cash flows, inventories, and ... Show More
4m 38s
May 23
Allianz Trade Global Survey 2025: Trade war, trade deals and their impacts on companies
Time for a new episode of Tomorrow! Today we’re diving into the results of the Allianz Trade Global Survey 2025, which asked 4,500 companies in China, France, Germany, Italy, Poland, Singapore, Spain, the UK and the US about their outlook for global trade - before and after the U ... Show More
5m 1s
Jun 2023
101: Biotechnology and Healthcare: A New Dawn? With Bob Bradway, CEO of Amgen
The late Steve Jobs of Apple said “I think the biggest innovation of the 21st century will be at the intersection of biology and technology, a new era is beginning”.
If you want see how biotech can change the world of health, whilst potentially being capable of creating extraordi ... Show More
39m 55s
Apr 2024
Can WeightWatchers survive the Wegovy era?
WeightWatchers is struggling. Launched in the early 1960s, the brand grew by helping members shed pounds through behavioural change programmes. Then, GLP-1 anti-obesity drugs hit the market, long-time spokesperson and board member Oprah Winfrey announced her departure, and the co ... Show More
17m 23s
Jul 2024
#358 🤓 Autoimmunity & Cancer Connections with Dr. Paul Anderson, NMD
Send us a textThis week on The Less Stressed Life Podcast, I am excited and honored to be joined by Dr. Paul Anderson, a recognized educator and clinician in integrative and naturopathic medicine with a focus on complex chronic illness and cancer. In this episode, we get super ne ... Show More
1h 16m
Apr 28
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter Susan Desmond-Hellmann is a physician and scientist whose remarkable career has spanned clinical medicine, oncology, biotech innovation, and global ... Show More
2h 5m